US$ 28.64
mechanism of action of glp 1 agonists Frontiers GLP-1 receptor agonists (GLP-1RAs): cardiovascular
Description
Liraglutide attenuates angiotensin II-induced aortic dissection and aortic aneurysm via inhibiting M1 macrophage polarization in APOE (-/-) mice

5 , e508e522 (2023)

A temporary program is expected to: Provide limited coverage for GLP-1 medications used for obesity Apply only to certain eligible individuals Run for a short period (through the end of 2026) This is a step forward, but its not a permanent solution and will not apply to everyone

Low blood sugar (hypoglycemia): This usually occurs only when Jardiance is used with insulin or certain other diabetes medications

Document ongoing symptoms and treatments
